I had a significant decline in gait post-stroke. Does that predict my decline in memory and thinking? My gait is still off 10 years later. The same study should have included abnormal participants like stroke and TBI survivors, like the real world contains rather than these cherry picked participants.
http://dgnews.docguide.com/comparing-gait-parameters-can-predict-decline-memory-thinking?
A study published in the Journal of Alzheimer's Disease found that
problems associated with gait can predict a significant decline in
memory and thinking.
Using the Rochester Epidemiology Project, researchers from the Mayo
Clinic, Rochester, Minnesota, examined medical records of residents from
Olmsted County, Minnesota, who were aged between 70 and 89 as of
October 1, 2004.
The analysis included 3,426 cognitively normal participants enrolled
in the Mayo Clinic Study of Aging who had a complete gait and
neuropsychological assessment.
At baseline and every 15 months (mean follow-up, 1.93 years),
participants had a study coordinator evaluation, neurological
examination, and a neuropsychological assessment using 9 tests that
covered 4 domains. Gait parameters were assessed with the GAITRite
instrument.
Spatial (stride length), temporal (ambulatory time, gait speed, step
count, cadence, double support time), and spatiotemporal (cadence) gait
parameters, and greater intraindividual variability in stride length,
swing time, and stance time were associated with a significant decline
in global cognition and in specific domains including memory, executive
function, visuospatial, and language.
The results of the study also support the role of computerised
analysis because the computer tool detected modifications before
impairment was detected with a standard neuropsychological test.
“The presence of gait disturbances increases with advancing age and
affects the independence of daily living, especially in the elderly,”
said lead author Rodolfo Savica, MD, Mayo Clinic. “Computerised gait
analysis is a simple, noninvasive test that potentially could be used to
identify patients at high risk for cognitive decline and to target
appropriate therapies.”
SOURCE: Mayo Clinic
No comments:
Post a Comment